id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-5570-0012,FDA,FDA-2017-D-5570,Select Updates for Recommendations for Clinical Laboratory Improvement Amendments of 1988 Waiver Applications for Manufacturers of In Vitro Diagnostic Devices; Draft Guidance for Industry and Food and Drug Administration Staff; Availability,Notice,Notice of Availability,2018-11-29T05:00:00Z,2018,11,2018-11-29T05:00:00Z,2019-02-28T04:59:59Z,2024-11-12T22:50:46Z,2018-25959,1,0,090000648390c0fa
FDA-2017-D-5570-0013,FDA,FDA-2017-D-5570,Draft Guidance for Industry and FDA_Select Updates for CLIA of 1988 Waiver Applications for Manufacturers of IVD Devices_11-29-2018,Other,Guidance,2018-11-29T05:00:00Z,2018,11,2018-11-29T05:00:00Z,2019-02-28T04:59:59Z,2024-11-12T22:50:08Z,,1,0,090000648390cc70
FDA-2017-D-5570-0006,FDA,FDA-2017-D-5570,Select Updates for Recommendations for Clinical Laboratory Improvement Amendments of 1988 Waiver Applications for  Manufacturers of In Vitro Diagnostic Devices; Draft Guidance for Industry and Food and Drug Administration Staff; Availability; Extension of Comment Period,Notice,Notice of Availability,2018-01-26T05:00:00Z,2018,1,2018-01-26T05:00:00Z,2018-03-31T03:59:59Z,2018-03-31T01:01:21Z,2018-01349,0,0,0900006482e6be59
FDA-2017-D-5570-0005,FDA,FDA-2017-D-5570,"Request for Extension from Coalition for CLIA Waiver Reform (Epstein Becker & Green, P.C.)",Other,Request for Extension,2018-01-08T05:00:00Z,2018,1,2018-01-08T05:00:00Z,,2018-01-08T16:20:10Z,,0,0,0900006482d9d48d